IntraCellular Therapies (ITCI)
(Delayed Data from NSDQ)
$76.48 USD
+1.62 (2.16%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $76.46 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.16 |
Last EPS Surprise | 48.39% |
ABR | 1.53 |
Earnings ESP
|
11.83% |
---|---|
Current Year | -0.53 |
Next Year | 0.88 |
EPS (TTM) | -1.16 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 158.13M | 171.65M | 659.53M | 888.15M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 160.10M | 178.10M | 668.26M | 962.50M |
Low Estimate | 154.34M | 169.04M | 651.90M | 786.42M |
Year ago Sales | 110.79M | 126.17M | 464.37M | 659.53M |
Year over Year Growth Est. | 42.73% | 36.05% | 42.03% | 34.66% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.14 | -0.53 | 0.88 |
# of Estimates | 7 | 5 | 8 | 7 |
Most Recent Consensus | -0.16 | -0.08 | -0.38 | NA |
High Estimate | -0.12 | -0.08 | -0.36 | 1.65 |
Low Estimate | -0.24 | -0.20 | -0.69 | -0.42 |
Year ago EPS | -0.45 | -0.25 | -1.46 | -0.53 |
Year over Year Growth Est. | 57.78% | 44.00% | 63.70% | 266.54% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 2 | 2 | 2 |
Down Last 60 Days | 1 | 3 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.14 | -0.53 | 0.88 |
7 Days Ago | -0.19 | -0.14 | -0.53 | 0.88 |
30 Days Ago | -0.20 | -0.13 | -0.51 | 0.93 |
60 Days Ago | -0.19 | -0.12 | -0.53 | 0.93 |
90 Days Ago | -0.23 | -0.09 | -0.62 | 0.90 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.17 | -0.08 | -0.44 | 1.12 |
Zacks Consensus Estimate | -0.19 | -0.14 | -0.53 | 0.88 |
Earnings ESP | 11.83% | 42.86% | 17.18% | 26.50% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.16 | -0.30 | -0.25 | -0.45 | NA |
Estimate | -0.31 | -0.44 | -0.59 | -0.62 | NA |
Difference | 0.15 | 0.14 | 0.34 | 0.17 | 0.20 |
Surprise | 48.39% | 31.82% | 57.63% | 27.42% | 41.32% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more